Studies on quinoline and isoquinoline derivatives. VIII. Hydration and hydrogenation of ethynyl substituents attached to the pyridine moiety of quinoline and isoquinoline rings

DOI: 10.1248/cpb.29.3554

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 3554 - 3560 (1981)

Update date:2022-08-02

Topics:

Authors:

Konno Konno

Shiraiwa

Yamanaka

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.29.3554

Full text of DOI:10.1248/cpb.29.3554

NII-Electronic Library Service

Products guided by the article

Product name:2-Isoquinolin-3-yl-1-phenyl-ethanone

Cas No:80998-84-1

R&D Labs maybe for 80998-84-1

shanghai meicheng chemical co .,ltd(expird)

Contact:+86-21-50677091

Address:Room 302, Building 7, No.1000, Jinhai Road
Shanghai Micro-mega Industry Co., Ltd.

Contact:0086-21-34628682;57153848

Address:Rm413,No.413,West Meilong Road, Minhang District,Shanghai P R China
Shanghai Rainbow Chemistry Co., Ltd.

Contact:+86-21-64968086-5815/5812

Address:3rd floor, Building 7, 251 Faladi Road, Zhangjiang Hi-Tech Park, Pudong District, Shanghai, P.R. China
Linyi Shengxin Pharmaceutical R&D Co., Ltd

Contact:+86-18653953873

Address:West First of Yufeng Road, Yishui County
Zhengzhou Gecko Scientific Inc.

Contact:0371-88884176

Address:56 Hongzhuan Road, Zhengzhou, China

Relevant to this article

Doi:10.1016/S0020-1693(00)88578-3
(1981)
Tricyclic Heteroaromatic Ring Systems III. Synthesis of 1H,6H-Dipyrazolo<3,4-b:3',4'-d>pyridin-3-ones

Doi:10.1007/BF00814345
(1982)
On the reactivity of isoxazoles with Mo(CO)₆

Doi:10.1002/jhet.5570410518
(2004)
Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from Hit to Clinic

Doi:10.1021/jm2007062
(2011)
Syntheses of derivatives of lacto-N-biose. I. 4,6-Di-O-acetyl-3-O-(tetra-O-acetyl-β-D-galactopyranosyl)-2-deoxy-2-phthalimido-α,β-D-glucopyranosyl chloride

Doi:10.1139/v82-010
(1982)
Synthesis and autooxidative transformation of 2-(2-aminophenyl)-4-hydroxy-3-phenyl-1-isoquinolone

Doi:10.1007/BF00513293
(1982)

Article Doi